Music |
Video |
Movies |
Chart |
Show |
EGFR TKI Resistance: Progress and Challenges (MedEdOTG) View | |
EGFR TKI Resistance: Targeting MET Amplification (MedEdOTG) View | |
2020 TTF EGFR SESSION QA PANEL Does Progression Always Occur on Osimertinib (Tagrisso) (GRACE - Global Resource for Advancing Cancer Education) View | |
Quickfire Updates From Chicago: What’s New for EGFR TKI Refractory and Resistant Non-Small Cell L... (Medscape) View | |
Resistance Mechanisms in EGFR+ NSCLC (OncLive) View | |
EGFR Mechanisms of Resistance (OncLive) View | |
Tackling EGFR Exon 20 Mutations: Clinical Challenges, New Insights Part 1 (MedEdOTG) View | |
Panel Discussion: Managing Patients with Acquired EGFR Resistance (MedEdOTG) View | |
Case 4: Metastatic EGFR+ NSCLC Progressing on Osimertinib (Targeted Oncology) View | |
NSCLC: EGFR Inhibition and Resistance Mechanisms (OncLive) View |